Indicated for: peptic ulcer; gastroesophageal reflux
Route of administration: oral
Substance: nizatidine (H2 receptor antagonist)
ATC: A02BA04 (Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists)
Nizatidine is an H2 receptor antagonist used in the treatment of gastric and duodenal ulcers, as well as gastroesophageal reflux disease (GERD). It works by reducing the production of gastric acid.
The medication is administered orally, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and avoid alcohol or foods that may worsen symptoms.
Patients should be aware of potential side effects, such as headaches, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include headaches, nausea, and diarrhea. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before use.